The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118903408 11890340 8 F 20160707 20160105 20160711 EXP US-GLAXOSMITHKLINE-US2015183844 GLAXOSMITHKLINE 0.00 F Y 68.27000 KG 20160711 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118903408 11890340 1 PS REQUIP XL ROPINIROLE HYDROCHLORIDE 1 Oral 4 MG, QD Y UNKNOWN 22008 4 MG PROLONGED-RELEASE TABLET QD
118903408 11890340 2 SS REQUIP XL ROPINIROLE HYDROCHLORIDE 1 6 MG, UNK Y 22008 6 MG PROLONGED-RELEASE TABLET
118903408 11890340 3 SS REQUIP XL ROPINIROLE HYDROCHLORIDE 1 8 MG, UNK Y 22008 8 MG PROLONGED-RELEASE TABLET
118903408 11890340 4 SS ROPINIROLE HYDROCHLORIDE. ROPINIROLE HYDROCHLORIDE 1 UNK Y 0
118903408 11890340 5 C AMANTADINE HYDROCHLORIDE. AMANTADINE HYDROCHLORIDE 1 UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118903408 11890340 1 Parkinson's disease
118903408 11890340 4 Parkinson's disease

Outcome of event

Event ID CASEID OUTC COD
118903408 11890340 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118903408 11890340 Abnormal behaviour
118903408 11890340 Adverse drug reaction
118903408 11890340 Asthenia
118903408 11890340 Crying
118903408 11890340 Depression
118903408 11890340 Drug dose omission
118903408 11890340 Drug ineffective
118903408 11890340 Economic problem
118903408 11890340 Emotional distress
118903408 11890340 Fear
118903408 11890340 Gambling
118903408 11890340 Gambling disorder
118903408 11890340 Hallucination
118903408 11890340 Hallucination, auditory
118903408 11890340 Hallucination, visual
118903408 11890340 Headache
118903408 11890340 Ill-defined disorder
118903408 11890340 Insomnia
118903408 11890340 Malaise
118903408 11890340 Mental disorder
118903408 11890340 Obsessive-compulsive disorder
118903408 11890340 Panic attack
118903408 11890340 Parkinson's disease
118903408 11890340 Product label issue
118903408 11890340 Stress
118903408 11890340 Suicidal ideation
118903408 11890340 Thinking abnormal
118903408 11890340 Tremor
118903408 11890340 Vomiting
118903408 11890340 Withdrawal syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118903408 11890340 1 201011 2014 0
118903408 11890340 4 201408 0